Skip to content
DataLookout
Menu

CREATE-MOMNCT07795853

Creatine for Recovery and Thinking in Mothers

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 2 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened
    • Primary and study completion pushed from May 10, 2027 to Jul 10, 2027
    • Start date changed from estimate of Sep 8, 2026 to Sep 28, 2026
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Repeated Sprint Ability Peak Power
Timeframe: Change from baseline to 4 weeks post-supplementation.
Fatigue Index
Timeframe: Change from baseline to 4 weeks post-supplementation.

Secondary (4)

Skeletal Muscle Oxygen Recovery
Executive Function
Working Memory
Brain Creatine Concentration

Arms and interventions

Low-Dose Creatine MonohydrateExperimental

Participants consume 5 grams per day of creatine monohydrate for 28 consecutive days.

High-dose Creatine MonohydrateExperimental

Participants consume 10 grams per day of creatine monohydrate for 28 consecutive days.

Dietary supplements: Creatine Monohdyrate

Sites

1 site in 1 country

  • Applied Physiology LaboratoryChapel Hill, North Carolina, United States